CYTR

CYTRX CORPCIK 799698 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for CYTR PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for CYTR

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Snowdy Stephen	Chief Executive Officer	1	$0	$0	2022-01-10
Simpson Jennifer K.	Director	2	$0	$0	2021-12-15
Brien Earl W	Director	6	$0	$0	2020-08-14
Caldwell Joel K	Director	6	$0	$0	2020-08-07
IGNARRO LOUIS	Director	12	$0	$0	2020-08-07
KRIEGSMAN STEVEN A	President, CEO, Board Chairman	15	$51.3K	$0	2020-08-07
CALOZ JOHN Y	Chief Financial Officer	10	$10.3K	$0	2019-12-13
Kratz Felix	Vice President Drug Discovery	1	$0	$0	2017-12-15
Chawla Anita J	Director	2	$0	$0	2016-12-15
Wieland Douglas Scott	Sr. VP - Drug Development	5	$0	$0	2016-12-15
LEVITT DANIEL J	EVP and Chief Medical Officer	11	$29.0K	$0	2016-12-15
RUBINFELD JOSEPH	Director	8	$0	$0	2016-12-15
Ware Olivia C	Chief Commercial Officer	1	$0	$0	2016-01-11
SELTER ERIC JAY	Director	1	$0	$0	2015-12-15
Cohen Cheryl	Director	1	$0	$0	2015-12-15
Levin Ben	SVP-Legal Affairs/GC/Secy	6	$10.9K	$0	2015-12-15
Wennekamp Richard L.	Director	6	$36.2K	$0	2015-12-15
Patterson Scott Bradford	10% Owner	36	$8.47M	$0	2013-12-10
SELTER MARVIN R	Director	17	$31.0K	$0	2013-12-10
LINK MAX	Director	5	$66.4K	$0	2013-12-10

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Snowdy Stephen	Chief Executive Officer	A Award deriv	2022-01-10	2022-01-12	300,000	—	$0	300,000	SEC↗
Simpson Jennifer K.	Director	A Award deriv	2021-12-15	2022-01-11	50,000	—	$0	50,000	SEC↗
Simpson Jennifer K.	Director	A Award	2021-12-15	2021-12-17	25,000	—	$0	25,000	SEC↗
Brien Earl W	Director	M Exercise deriv	2020-08-14	2020-08-20	150,000	—	$0	300,000	SEC↗
Brien Earl W	Director	M Exercise	2020-08-14	2020-08-20	150,000	$0.26	$39.0K	590,247	SEC↗
Caldwell Joel K	Director	M Exercise deriv	2020-08-07	2020-08-13	450,000	—	$0	0	SEC↗
IGNARRO LOUIS	Director	M Exercise deriv	2020-08-07	2020-08-13	700,000	—	$0	0	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	M Exercise deriv	2020-08-07	2020-08-13	3,000,000	—	$0	0	SEC↗
Caldwell Joel K	Director	F Tax w/h	2020-08-07	2020-08-13	174,627	$0.67	$117.0K	335,373	SEC↗
Caldwell Joel K	Director	M Exercise	2020-08-07	2020-08-13	450,000	$0.26	$117.0K	510,000	SEC↗
IGNARRO LOUIS	Director	M Exercise	2020-08-07	2020-08-13	700,000	$0.26	$182.0K	872,427	SEC↗
IGNARRO LOUIS	Director	F Tax w/h	2020-08-07	2020-08-13	271,642	$0.67	$182.0K	600,785	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	M Exercise	2020-08-07	2020-08-13	3,000,000	$0.26	$780.0K	4,832,217	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	F Tax w/h	2020-08-07	2020-08-13	1,164,179	$0.67	$780.0K	3,668,038	SEC↗
Brien Earl W	Director	A Award deriv	2019-12-13	2019-12-17	450,000	—	$0	450,000	SEC↗
Caldwell Joel K	Director	A Award deriv	2019-12-13	2019-12-17	450,000	—	$0	450,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2019-12-13	2019-12-17	350,000	—	$0	350,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2019-12-13	2019-12-17	700,000	—	$0	700,000	SEC↗
KRIEGSMAN STEVEN A	CEO	A Award deriv	2019-12-13	2019-12-17	3,000,000	—	$0	3,000,000	SEC↗
Kratz Felix	Vice President Drug Discover	A Award deriv	2017-12-15	2018-01-02	25,000	—	$0	25,000	SEC↗
KRIEGSMAN STEVEN A	CEO	A Award deriv	2017-12-15	2017-12-19	208,334	—	$0	208,334	SEC↗
Brien Earl W	Director	A Award deriv	2017-12-15	2017-12-19	70,000	—	$0	70,000	SEC↗
Caldwell Joel K	Director	A Award deriv	2017-12-15	2017-12-19	30,000	—	$0	30,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2017-12-15	2017-12-19	58,334	—	$0	58,334	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2017-12-15	2017-12-19	30,000	—	$0	30,000	SEC↗
KRIEGSMAN STEVEN A	CEO	A Award	2017-12-15	2017-12-19	387,597	$1.75	$678.3K	387,597	SEC↗
Caldwell Joel K	Director	A Award deriv	2017-07-12	2017-09-06	180,000	—	$0	180,000	SEC↗
Brien Earl W	Director	A Award deriv	2016-12-15	2016-12-19	180,000	—	$0	180,000	SEC↗
Chawla Anita J	Director	A Award deriv	2016-12-15	2016-12-19	180,000	—	$0	180,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2016-12-15	2016-12-19	180,000	—	$0	180,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2016-12-15	2016-12-19	180,000	—	$0	180,000	SEC↗
KRIEGSMAN STEVEN A	CEO	A Award deriv	2016-12-15	2016-12-19	1,250,000	—	$0	1,250,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2016-12-15	2016-12-19	350,000	—	$0	350,000	SEC↗
Wieland Douglas Scott	Sr VP - Drug Development	A Award deriv	2016-12-15	2016-12-19	150,000	—	$0	150,000	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award deriv	2016-12-15	2016-12-19	400,000	—	$0	400,000	SEC↗
KRIEGSMAN STEVEN A	CEO	A Award deriv	2016-12-15	2016-12-20	1,250,000	—	$0	1,250,000	SEC↗
KRIEGSMAN STEVEN A	CEO	A Award	2016-12-15	2016-12-20	2,325,581	$0.43	$1000.0K	2,325,581	SEC↗
Brien Earl W	Director	A Award deriv	2016-12-02	2016-12-06	180,000	—	$0	180,000	SEC↗
Ware Olivia C	Chief Commercial Officer	A Award deriv	2016-01-11	2016-01-14	350,000	—	$0	350,000	SEC↗
KRIEGSMAN STEVEN A	CEO and Chairman of Board	A Award deriv	2015-12-15	2015-12-17	1,000,000	—	$0	1,000,000	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award deriv	2015-12-15	2015-12-17	500,000	—	$0	500,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2015-12-15	2015-12-17	300,000	—	$0	300,000	SEC↗
Chawla Anita J	Director	A Award deriv	2015-12-15	2015-12-17	180,000	—	$0	180,000	SEC↗
Cohen Cheryl	Director	A Award deriv	2015-12-15	2015-12-17	180,000	—	$0	180,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2015-12-15	2015-12-17	180,000	—	$0	180,000	SEC↗
Levin Ben	SVP-Legal Affairs/GC/Secy	A Award deriv	2015-12-15	2015-12-17	300,000	—	$0	300,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2015-12-15	2015-12-17	180,000	—	$0	180,000	SEC↗
SELTER ERIC JAY	Director	A Award deriv	2015-12-15	2015-12-17	180,000	—	$0	180,000	SEC↗
Wieland Douglas Scott	Sr VP - Drug Development	A Award deriv	2015-12-15	2015-12-17	100,000	—	$0	100,000	SEC↗
Wennekamp Richard L.	Director	A Award deriv	2015-12-15	2014-12-16	180,000	—	$0	180,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2014-12-15	2014-12-16	180,000	—	$0	180,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2014-12-15	2014-12-16	180,000	—	$0	180,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2014-12-15	2014-12-16	180,000	—	$0	180,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2014-12-15	2014-12-16	180,000	—	$0	180,000	SEC↗
KRIEGSMAN STEVEN A	President, CEO, Board Chairm	A Award deriv	2014-12-15	2014-12-16	600,000	—	$0	600,000	SEC↗
Levin Ben	GC/SVP-Legal Affairs/Secy	A Award deriv	2014-12-15	2014-12-17	200,000	—	$0	200,000	SEC↗
Wieland Douglas Scott	Sr VP - Drug Development	A Award deriv	2014-12-15	2014-12-17	200,000	—	$0	200,000	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award deriv	2014-12-15	2014-12-17	400,000	—	$0	400,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2014-12-15	2014-12-17	200,000	—	$0	200,000	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award	2014-01-01	2014-01-03	100,000	—	$0	214,286	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award	2014-01-01	2014-01-03	100,000	—	$0	157,706	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award	2014-01-01	2014-01-10	100,000	—	$0	157,983	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award	2014-01-01	2014-01-28	100,000	—	$0	161,036	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2013-12-10	2013-12-11	150,000	—	$0	150,000	SEC↗
Wieland Douglas Scott	Sr. VP - Drug Development	A Award deriv	2013-12-10	2013-12-11	150,000	—	$0	150,000	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	A Award deriv	2013-12-10	2013-12-11	925,000	—	$0	925,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2013-12-10	2013-12-12	180,000	—	$0	180,000	SEC↗
LINK MAX	Director	A Award deriv	2013-12-10	2013-12-12	180,000	—	$0	180,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2013-12-10	2013-12-12	180,000	—	$0	180,000	SEC↗
Wennekamp Richard L.	Director	A Award deriv	2013-12-10	2013-12-12	180,000	—	$0	180,000	SEC↗
Levin Ben	GC/SVP Legal Affairs/Secy	A Award deriv	2013-12-10	2013-12-12	300,000	—	$0	300,000	SEC↗
LEVITT DANIEL J	EVP and Chief Medical Office	A Award deriv	2013-12-10	2013-12-12	500,000	—	$0	500,000	SEC↗
SELTER MARVIN R	Director	A Award deriv	2013-12-10	2013-12-12	180,000	—	$0	180,000	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2013-12-10	2013-12-12	180,000	—	$0	0	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-12-10	2013-12-12	334,979	$2.40	$803.9K	4,577,605	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-12-03	2013-12-03	42,131	$2.35	$99.0K	4,912,584	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-12-02	2013-12-03	77,148	$2.39	$184.4K	4,870,453	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-11-29	2013-12-03	165,700	$2.48	$410.9K	4,793,305	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-11-07	2013-11-08	50,000	$2.06	$103.0K	4,627,605	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-04-01	2013-04-03	4,083	$2.70	$11.0K	4,577,605	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-03-20	2013-03-20	8,420	$2.57	$21.6K	4,569,542	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-03-20	2013-03-22	3,980	$2.61	$10.4K	4,573,522	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-03-19	2013-03-20	24,100	$2.58	$62.2K	4,561,122	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-03-18	2013-03-20	3,000	$2.56	$7.7K	4,537,022	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-03-13	2013-03-14	360	$2.52	$907	4,534,022	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2013-03-11	2013-03-14	55,000	$2.67	$146.8K	4,533,662	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	A Award deriv	2013-03-08	2013-03-12	74,176	—	$0	74,176	SEC↗
LEVITT DANIEL J	Chief Medical Officer	A Award	2012-12-31	2013-01-02	100,000	—	$0	200,000	SEC↗
LEVITT DANIEL J	EVP & Chief Medical Officer	A Award	2012-12-31	2013-01-07	100,000	—	$0	114,286	SEC↗
Levin Ben	GC/VP Legal Affairs/Secretar	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
Wieland Douglas Scott	Sr. VP - Drug Development	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
CALOZ JOHN Y	Chief Financial Officer	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
LINK MAX	Director	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
Wennekamp Richard L.	Director	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2012-12-10	2012-12-11	30,000	—	$0	30,000	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	100,000	—	$0	0	SEC↗
SELTER MARVIN R	Director	A Award deriv	2012-12-10	2012-12-11	100,000	—	$0	100,000	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	1,428	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	1,428	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	7,142	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	7,142	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	714	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	2,142	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	3,572	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	3,572	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	3,572	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	7,142	—	$0	0	SEC↗
SELTER MARVIN R	Director	G Gift deriv	2012-12-10	2012-12-11	7,142	—	$0	0	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-10-22	2012-10-23	115,000	$2.51	$288.6K	4,478,662	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-10-19	2012-10-23	65,000	$2.51	$163.2K	4,363,662	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-10-18	2012-10-18	1,200,000	$2.50	$3.00M	4,298,662	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-28	2012-06-28	16,000	$4.90	$78.4K	3,098,662	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-27	2012-06-28	15,824	$5.23	$82.8K	3,082,662	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-26	2012-06-28	13,000	$5.32	$69.2K	3,066,838	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-25	2012-06-25	17,835	$5.16	$92.0K	3,053,838	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-22	2012-06-25	5,334	$4.74	$25.3K	3,036,003	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-21	2012-06-25	4,293	$4.61	$19.8K	3,030,669	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-20	2012-06-20	7,283	$4.65	$33.9K	3,026,376	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-19	2012-06-20	9,210	$4.48	$41.3K	3,019,093	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-18	2012-06-20	4,621	$4.25	$19.6K	3,009,883	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-15	2012-06-18	3,558	$3.89	$13.8K	3,005,262	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-14	2012-06-18	10,976	$3.83	$42.0K	3,001,704	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-13	2012-06-14	14,176	$3.88	$55.0K	2,990,728	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-12	2012-06-14	5,594	$3.80	$21.3K	2,976,552	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-11	2012-06-12	23,399	$3.80	$88.9K	2,970,958	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-08	2012-06-12	20,933	$3.80	$79.5K	2,947,559	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-07	2012-06-07	53,635	$3.85	$206.5K	2,926,626	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-06	2012-06-07	24,894	$3.97	$98.8K	2,872,991	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-05	2012-06-07	66,704	$3.85	$256.8K	2,848,097	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-04	2012-06-04	221,000	$3.53	$780.1K	2,863,292	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-06-01	2012-06-04	86,696	$3.74	$324.2K	2,642,292	SEC↗
Patterson Scott Bradford	10% Owner	P Buy	2012-05-31	2012-06-04	190,200	$3.83	$728.5K	2,555,596	SEC↗
IGNARRO LOUIS	Director	A Award deriv	2012-05-14	2012-05-15	50,000	—	$0	50,000	SEC↗
LINK MAX	Director	A Award deriv	2012-05-14	2012-05-15	50,000	—	$0	50,000	SEC↗
RUBINFELD JOSEPH	Director	A Award deriv	2012-05-14	2012-05-15	50,000	—	$0	50,000	SEC↗
SELTER MARVIN R	Director	A Award deriv	2012-05-14	2012-05-15	50,000	—	$0	50,000	SEC↗
Wennekamp Richard L.	Director	A Award deriv	2012-05-14	2012-05-15	50,000	—	$0	50,000	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	P Buy	2012-02-23	2012-02-24	105,517	$0.33	$34.8K	4,179,776	SEC↗
Levin Ben	GC/VP Legal Affairs/Secy	P Buy	2012-02-23	2012-02-24	22,329	$0.33	$7.4K	33,578	SEC↗
Wennekamp Richard L.	Director	P Buy	2012-02-23	2012-02-24	74,455	$0.33	$24.6K	116,965	SEC↗
CALOZ JOHN Y	Chief Financial Officer	P Buy	2012-02-23	2012-02-24	21,141	$0.33	$7.0K	31,792	SEC↗
LINK MAX	Director	P Buy	2012-02-23	2012-02-24	136,540	$0.33	$45.1K	260,305	SEC↗
KRIEGSMAN STEVEN A	Chief Executive Officer	P Buy	2012-02-22	2012-02-24	53,159	$0.31	$16.5K	4,074,259	SEC↗
Levin Ben	GC/VP Legal Affairs/Secy	P Buy	2012-02-22	2012-02-24	11,249	$0.31	$3.5K	11,249	SEC↗
LEVITT DANIEL J	Chief Medical Officer	P Buy	2012-02-22	2012-02-24	100,000	$0.29	$29.0K	100,000	SEC↗
Wennekamp Richard L.	Director	P Buy	2012-02-22	2012-02-24	37,510	$0.31	$11.6K	42,510	SEC↗
SELTER MARVIN R	Director	P Buy	2012-02-22	2012-02-24	100,000	$0.31	$31.0K	253,193	SEC↗
CALOZ JOHN Y	Chief Financial Officer	P Buy	2012-02-22	2012-02-24	10,651	$0.31	$3.3K	10,651	SEC↗
LINK MAX	Director	P Buy	2012-02-22	2012-02-24	68,789	$0.31	$21.3K	123,765	SEC↗